First‐Line Lorlatinib in Striatin–Anaplastic Lymphoma Kinase‐Positive Lung Adenocarcinoma: A Case Report and Literature Review

Masaru Maebeya, Shinobu Tamura, Takeshi Shono, Takanobu Hoso, Hitomi Tatsuta

Open source

DOI
10.1002/rcr2.70750
Published
2026-09
Container
Respirology Case Reports
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/rcr2.70750,
  title = {First‐Line Lorlatinib in Striatin–Anaplastic Lymphoma Kinase‐Positive Lung Adenocarcinoma: A Case Report and Literature Review},
  author = {Masaru Maebeya and Shinobu Tamura and Takeshi Shono and Takanobu Hoso and Hitomi Tatsuta},
  year = {2026},
  journal = {Respirology Case Reports},
  doi = {10.1002/rcr2.70750},
  url = {https://doi.org/10.1002/rcr2.70750}
}

RIS

TY  - JOUR
TI  - First‐Line Lorlatinib in Striatin–Anaplastic Lymphoma Kinase‐Positive Lung Adenocarcinoma: A Case Report and Literature Review
AU  - Masaru Maebeya
AU  - Shinobu Tamura
AU  - Takeshi Shono
AU  - Takanobu Hoso
AU  - Hitomi Tatsuta
PY  - 2026
JO  - Respirology Case Reports
DO  - 10.1002/rcr2.70750
UR  - https://doi.org/10.1002/rcr2.70750
ER  - 

APA

Maebeya, M., Tamura, S., Shono, T., Hoso, T., & Tatsuta, H. (2026). First‐Line Lorlatinib in Striatin–Anaplastic Lymphoma Kinase‐Positive Lung Adenocarcinoma: A Case Report and Literature Review. Respirology Case Reports. https://doi.org/10.1002/rcr2.70750

Source records